{"id":996591,"date":"2026-08-19T08:05:17","date_gmt":"2026-08-19T12:05:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/"},"modified":"2026-08-19T08:05:17","modified_gmt":"2026-08-19T12:05:17","slug":"stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/","title":{"rendered":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm"},"content":{"rendered":"<p>        <!--.bwuline { text-decoration: underline }\n.bwalignl { text-align: left }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm<\/b><\/p>\n<p>PHILADELPHIA&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kaskelalaw.com%2F&amp;esheet=54591634&amp;newsitemid=20260819717758&amp;lan=en-US&amp;anchor=Kaskela+Law&amp;index=1&amp;md5=a3e20d45dad571a12d3bab0a9aead9df\">Kaskela Law<\/a> is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\u201cAmneal\u201d) on behalf of the company\u2019s current shareholders.<\/p>\n<p>The investigation seeks to determine whether Amneal or the company\u2019s officers and\/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.<\/p>\n<p><i><b>Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 \u2013 0750, or by email at <\/b><\/i><a rel=\"nofollow\" href=\"mailto:abell@kaskelalaw.com\"><i><b>abell@kaskelalaw.com<\/b><\/i><\/a><i><b>. <\/b><\/i>Investors may contact the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser) and filling out our online form:<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkaskelalaw.com%2Fcase%2Famneal%2F&amp;esheet=54591634&amp;newsitemid=20260819717758&amp;lan=en-US&amp;anchor=https%3A%2F%2Fkaskelalaw.com%2Fcase%2Famneal%2F&amp;index=2&amp;md5=652d992d1bd2f6d1662be7a73ec571b2\"><i><b>https:\/\/kaskelalaw.com\/case\/amneal\/<\/b><\/i><\/a><\/p>\n<p><b><span class=\"bwuline\">ABOUT KASKELA LAW:<\/span><\/b><br \/>Kaskela Law LLC <i><span class=\"bwuline\">exclusively<\/span><\/i> represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation on a contingent basis (<i>i.e.<\/i>, the firm\u2019s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has helped to recover over $500 million for investors. For additional information about Kaskela Law LLC, including the firm\u2019s recent notable recoveries for investors, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkaskelalaw.com%2Ffeatured-cases%2F&amp;esheet=54591634&amp;newsitemid=20260819717758&amp;lan=en-US&amp;anchor=www.kaskelalaw.com&amp;index=3&amp;md5=172e10f47abcd4e5bf885ff4b6f076e7\">www.kaskelalaw.com<\/a>.<\/p>\n<p>This communication may constitute attorney advertising in certain jurisdictions.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260819717758\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260819717758\/en\/<\/a><\/span><\/p>\n<p class=\"bwalignl\"><b>KASKELA LAW LLC<\/b><br \/>D. Seamus Kaskela, Esq.<br \/>Adrienne Bell, Esq.<br \/>1234 West Chester Pike<br \/>West Chester, PA 19380<br \/>Newtown Square, PA 19073<br \/>(484) 229 &#8211; 0750<br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.kaskelalaw.com%2F&amp;esheet=54591634&amp;newsitemid=20260819717758&amp;lan=en-US&amp;anchor=www.kaskelalaw.com&amp;index=4&amp;md5=e1234f5bc785259500f30fe73e2f28ca\">www.kaskelalaw.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Pennsylvania United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260819717758\/en\/780882\/3\/KASKELA_LAW_LOGO_2020.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211;Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\u201cAmneal\u201d) on behalf of the company\u2019s current shareholders. The investigation seeks to determine whether Amneal or the company\u2019s officers and\/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 \u2013 0750, or by email at abell@kaskelalaw.com. Investors may contact the firm by clicking on the following link (or if necessary, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-996591","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211;Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\u201cAmneal\u201d) on behalf of the company\u2019s current shareholders. The investigation seeks to determine whether Amneal or the company\u2019s officers and\/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 \u2013 0750, or by email at abell@kaskelalaw.com. Investors may contact the firm by clicking on the following link (or if necessary, &hellip; Continue reading &quot;STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-19T12:05:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm\",\"datePublished\":\"2026-08-19T12:05:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/\",\"name\":\"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-08-19T12:05:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Market Newsdesk","og_description":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211;Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\u201cAmneal\u201d) on behalf of the company\u2019s current shareholders. The investigation seeks to determine whether Amneal or the company\u2019s officers and\/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 \u2013 0750, or by email at abell@kaskelalaw.com. Investors may contact the firm by clicking on the following link (or if necessary, &hellip; Continue reading \"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-19T12:05:17+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm","datePublished":"2026-08-19T12:05:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/","name":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-08-19T12:05:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260819717758r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stock-alert-kaskela-law-announces-shareholder-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-current-amrx-stockholders-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/996591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=996591"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/996591\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=996591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=996591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=996591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}